However, treatment with SGI-1776 inhibited growth (for MCL and AML), induced autophagy (for MM), and inhibited translation by negatively regulating phosphorylation of 4E-BP1. This evidence concerns the gene EIF4EBP1 and Miyoshi myopathy.